Lycia Therapeutics Inc. LYCA · SEC Filings

website

Lycia Therapeutics, Inc. operates as a clinical-stage biotechnology company. It engages in the disco...

Price30.36

Market Cap1.75 B

Float18.24 M

CountryUS

SectorHealthcare

ExchangeNASDAQ

Overview Filings Insights Dilution News Transcripts

Search in Documents

Open in Studio Login

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

Financials

TYPE

HEADLINE

FILED AT

News

TYPE

HEADLINE

FILED AT

Prospectus

TYPE

HEADLINE

FILED AT

424B4

IPO | Offering amount: $317,520,000 | Shares: 17,640,000 | Price: $18.000 | Bank: Jefferies

Oct 23, 2026

Registrations

TYPE

HEADLINE

FILED AT

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Oct 23, 2026

S-1MEF

Form S-1MEF - Registration adding securities to prior Form S-1 registration [Rule 462(b)]

Oct 22, 2026

8-A12B

Form 8-A12B - Registration of securities [Section 12(b)]

Oct 20, 2026

S-1/A

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

Oct 20, 2026

S-1

Form S-1 - General form for registration of securities under the Securities Act of 1933

Oct 5, 2026

DRS/A

Form DRS/A - Draft Registration Statement: [Amend]

Aug 27, 2026

Proxies

TYPE

HEADLINE

FILED AT

Ownerships

TYPE

HEADLINE

FILED AT

Other

TYPE

HEADLINE

FILED AT

EFFECT

Form EFFECT - Notice of Effectiveness

Oct 23, 2026